Organovo Holdings, Inc.

Symbol: ONVO

NASDAQ

1.03

USD

Market price today

  • -0.4827

    P/E Ratio

  • -0.0129

    PEG Ratio

  • 10.34M

    MRK Cap

  • 0.00%

    DIV Yield

Organovo Holdings, Inc. (ONVO) Stock Price & Analysis

Shares Outstanding

0M

Gross Profit Margin

-0.11%

Operating Profit Margin

-81.69%

Net Profit Margin

-76.95%

Return on Assets

-2.10%

Return on Equity

-1.78%

Return on Capital Employed

-2.75%

Company general description and statistics

Sector: Healthcare
Industry: Biotechnology
CEO:Mr. Keith E. Murphy
Full-time employees:18
City:Solana Beach
Address:11555 Sorrento Valley Road
IPO:2012-02-14
CIK:0001497253

Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company offers ExVive human liver tissue and ExVive human kidney tissue used for predictive preclinical testing of drug compounds. The company was incorporated in 2007 and is headquartered in Solana Beach, California.

General Outlook

When we look at how much money they make before expenses, they keep -0.107% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is -81.690%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of -76.950%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust -2.097% return, is a testament to Organovo Holdings, Inc.'s adeptness in optimizing resource deployment. Organovo Holdings, Inc.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of -1.784%. Furthermore, the proficiency of Organovo Holdings, Inc. in capital utilization is underscored by a remarkable -2.753% return on capital employed.

Stock Prices

Organovo Holdings, Inc.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $1.02, while its low point bottomed out at $0.9305. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Organovo Holdings, Inc.'s stock market.

Liquidity Ratios

Analyzing ONVO liquidity ratios reveals its financial health of the firm. The current ratio of 367.12% gauges short-term asset coverage for liabilities. The quick ratio (313.41%) assesses immediate liquidity, while the cash ratio (311.47%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio367.12%
Quick Ratio313.41%
Cash Ratio311.47%

Profitability Ratios

ONVO profitability indicators offer a lens into its earnings landscape. A pretax profit margin of -7885.54% underscores its earnings before tax deductions. The effective tax rate stands at 3.17%, revealing its tax efficiency. The net income per EBT, 97.58%, and the EBT per EBIT, 96.53%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of -8169.01%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin-7885.54%
Effective Tax Rate3.17%
Net Income per EBT97.58%
EBT per EBIT96.53%
EBIT per Revenue-8169.01%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 3.67, it details the span from stock purchase to revenue. The 3 days it takes to settle debts showcases its creditor relations. Meanwhile, a 3 cash conversion cycle and 733.33% receivables turnover rate reflect its cash flow efficiency and credit management, respectively.

cards.indicatorcards.value
Days of Sales Outstanding313
Operating Cycle49.77
Days of Payables Outstanding641
Cash Conversion Cycle-592
Receivables Turnover7.33
Payables Turnover0.57
Inventory Turnover268000.00
Fixed Asset Turnover0.11
Asset Turnover0.03

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, -1.83, and free cash flow per share, -1.86, depict cash generation on a per-share basis. The cash per share value, 0.58, showcases liquidity position. Lastly, the operating cash flow sales ratio, -69.07, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share-1.83
Free Cash Flow per Share-1.86
Cash per Share0.58
Operating Cash Flow Sales Ratio-69.07
Free Cash Flow to Operating Cash Flow Ratio1.01
Cash Flow Coverage Ratio-11.14
Short Term Coverage Ratio-33.30
Capital Expenditure Coverage Ratio-81.94
Dividend Paid and Capex Coverage Ratio-81.94

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 16.90%, highlights its total liabilities relative to assets. With a debt-equity ratio of 0.24, we discern the balance between debt and equity financing. The long-term debt to capitalization, 13.91%, and total debt to capitalization, 19.54%, ratios shed light on its capital structure. An interest coverage of 61.78 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Debt Ratio16.90%
Debt Equity Ratio0.24
Long Term Debt to Capitalization13.91%
Total Debt to Capitalization19.54%
Interest Coverage61.78
Cash Flow to Debt Ratio-11.14
Company Equity Multiplier1.44

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, -75.33%, indicates top-line expansion, while the gross profit growth, -94.33%, reveals profitability trends. EBIT growth, -54.46%, and operating income growth, -54.46%, offer insights into operational profitability progression. The net income growth, -50.76%, showcases bottom-line expansion, and the EPS growth, -50.00%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth-75.33%
Gross Profit Growth-94.33%
EBIT Growth-54.46%
Operating Income Growth-54.46%
Net Income Growth-50.76%
EPS Growth-50.00%
EPS Diluted Growth-50.00%
Weighted Average Shares Growth0.11%
Weighted Average Shares Diluted Growth0.11%
Operating Cash Flow Growth-46.79%
Free Cash Flow Growth-44.48%
10-Year Revenue Growth per Share-59.03%
5-Year Revenue Growth per Share-95.05%
3-Year Revenue Growth per Share-87.47%
10-Year Operating CF Growth per Share66.53%
5-Year Operating CF Growth per Share73.54%
3-Year Operating CF Growth per Share38.01%
10-Year Net Income Growth per Share71.98%
5-Year Net Income Growth per Share69.48%
3-Year Net Income Growth per Share31.42%
10-Year Shareholders Equity Growth per Share-86.68%
5-Year Shareholders Equity Growth per Share-78.84%
3-Year Shareholders Equity Growth per Share-57.21%
Asset Growth-38.99%
Book Value per Share Growth-49.31%
Debt Growth-17.32%
R&D Expense Growth167.62%
SGA Expenses Growth-5.64%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 1.45, and the price to book ratio, 1.45, reflect the market's valuation relative to the company's book value. The price to sales ratio, 46.58, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, -0.67, and price to operating cash flows, -0.54, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio1.45
Price to Book Ratio1.45
Price to Sales Ratio46.58
Price Cash Flow Ratio-0.54
Price Earnings to Growth Ratio-0.01
Enterprise Value Multiple-0.76
Price Fair Value1.45
Price to Operating Cash Flow Ratio-0.54
Price to Free Cash Flows Ratio-0.67
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Organovo Holdings, Inc. (ONVO) on the NASDAQ in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is -0.483 in 2024.

What is the ticker symbol of Organovo Holdings, Inc. stock?

The ticker symbol of Organovo Holdings, Inc. stock is ONVO.

What is company IPO date?

IPO date of Organovo Holdings, Inc. is 2012-02-14.

What is company current share price?

Current share price is 1.030 USD.

What is stock market cap today?

The market cap of stock today is 10341303.000.

What is PEG ratio in 2024?

The current -0.013 is -0.013 in 2024.

What is the number of employees in 2024?

In 2024 the company has 18.